Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

21.55
Delayed Data
As of 4:00pm ET
 +0.35 / +1.65%
Today’s Change
13.60
Today|||52-Week Range
33.00
+14.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues336.4M401.5M492.7M519.6M
 
 
 
 
 
Cost of Goods Sold59.6M72.1M77.9M86.5M
 
 
 
 
 
Depreciation And Amortization7.0M8.5M15.0M21.6M
 
 
 
 
 
 
Operating ExpensesGross Income269.8M320.9M399.7M411.5M
 
 
 
 
 
General Expenses238.6M268.5M354.8M421.3M
 
 
 
 
 
Research And Development53.9M73.5M149.2M203.4M
 
 
 
 
 
Total Operating Expenses305.2M349.1M447.8M529.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income31.2M52.4M44.9M-9.8M
 
 
 
 
 
Extraordinary Credit0.00236.0K0.00--
 
 
Extraordinary Charge-1.0M-16.4M-10.9M-26.2M
 
 
 
 
 
Interest Expense On Debt2.2M9.3M15.5M16.5M
 
 
 
 
 
Other Expenses182.0K379.0K411.0K9.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.9M28.0M19.4M-42.3M
 
 
 
 
 
Income Taxes-12.4M-10.3M-8.3M-6.7M
 
 
 
 
 
Minority Interest0.000.000.00-985.0K
 
 
Net Income16.4M17.7M11.1M-34.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.2M41.2M42.2M45.3M
 
 
 
 
 
Shares To Calculate EPS Diluted41.7M42.5M43.6M45.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.39$0.42$0.25-$0.76
 
 
 
 
 
EPS Diluted$0.39$0.42$0.25-$0.76